ReviewFrontiers in medicine2026

Limited benefits of neoadjuvant therapy on R0 resection rate and overall survival in patients with resectable or locally advanced PDAC in randomized controlled trials.

Hao Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.